Skip to main content
Premium Trial:

Request an Annual Quote

Genomatica Nabs UCSD, Penn State Bioengineering Licenses

NEW YORK, April 26-Privately held systems biology company Genomatica said on Wednesday that it has licensed bioengineering technology from the University of California, San Diego and the Pennsylvania State University.


These licenses, said the company, give it an edge in constraints-based modeling of metabolic and other regulatory processes.


Through the licenses, Genomatica gets access to the work of UCSD bioengineer Bernhard Paisson, and the regulatory network research of Penn State's Costas Maranas.


"These technologies will enable the integrated modeling of metabolism and regulation, positioning the company as a leader in the emerging field of in silico biology," said VP Christophe Schilling in a statement.


Constraints-based modeling, in Genomatica's work, seeks to integrate gene, protein, metabolite and phenotype information to create models of cellular activity.


Genomatica is based in San Diego, Calif.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.